• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低 CDCA5 通过调控 PDS5A 抑制乳腺癌细胞的恶性进展。

Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A.

机构信息

Yun Kang School of Medicine and Health, NanFang College, Guangzhou, Guangdong 510970, P.R. China.

Department of Thyroid and Breast Surgery, The Second People's Hospital of Nantong, Nantong, Jiangsu 226000, P. R. China.

出版信息

Mol Med Rep. 2022 Jun;25(6). doi: 10.3892/mmr.2022.12725. Epub 2022 May 4.

DOI:10.3892/mmr.2022.12725
PMID:35506437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9133959/
Abstract

Breast cancer is one of the most common malignant tumors in women. Cell division cycle‑associated 5 (CDCA5) is closely associated with the behavior of various cancer types. The aim of the present study was to explore the effect of CDCA5 on breast cancer. Western blot analysis and reverse transcription‑quantitative PCR were used to detect the expression level of CDCA5 in human normal mammary cells and human breast cancer cell lines. To determine its function in MDA‑MB‑231 cells, CDCA5 was silenced in MDA‑MB‑231 cells by transient short hairpin RNA transfection. Cell Counting Kit‑8 and clonogenicity assays were used to evaluate cell proliferation. Wound healing and Transwell assays were used to detect cell invasion and migration. Western blot analysis was used to detect the protein expressions of Ki67 and PCNA associated with proliferation, MMP2 and MMP9 associated with migration. CDCA5 was found to be markedly increased in breast cancer cell lines. CDCA5 knockdown was able to suppress cell proliferation, invasion and migration. CDCA5 inhibition downregulated PDS5 cohesin‑associated factor A (PDS5A) expression in breast cancer cells. PDS5A overexpression was found to reverse the effect of CDCA5 inhibition on breast cancer cell proliferation and migration. CDCA5 knockdown was shown to suppress the malignant progression of breast cancer cells by regulating PDS5A. The present findings may provide new potential targets for breast cancer therapy.

摘要

乳腺癌是女性最常见的恶性肿瘤之一。细胞分裂周期相关蛋白 5(CDCA5)与多种癌症类型的行为密切相关。本研究旨在探讨 CDCA5 对乳腺癌的影响。Western blot 分析和逆转录-定量 PCR 用于检测人正常乳腺细胞和人乳腺癌细胞系中 CDCA5 的表达水平。为了确定其在 MDA-MB-231 细胞中的功能,通过瞬时短发夹 RNA 转染沉默 MDA-MB-231 细胞中的 CDCA5。细胞计数试剂盒-8 和集落形成实验用于评估细胞增殖。伤口愈合和 Transwell 实验用于检测细胞侵袭和迁移。Western blot 分析用于检测与增殖相关的 Ki67 和 PCNA、与迁移相关的 MMP2 和 MMP9 的蛋白表达。发现 CDCA5 在乳腺癌细胞系中明显增加。CDCA5 敲低能够抑制细胞增殖、侵袭和迁移。CDCA5 抑制下调了乳腺癌细胞中 PDS5 黏合因子 A(PDS5A)的表达。发现 PDS5A 过表达能够逆转 CDCA5 抑制对乳腺癌细胞增殖和迁移的影响。CDCA5 敲低通过调节 PDS5A 抑制乳腺癌细胞的恶性进展。这些发现可能为乳腺癌治疗提供新的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/ddb6419fefdd/mmr-25-06-12725-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/07c346712a50/mmr-25-06-12725-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/9c8f7c151d8e/mmr-25-06-12725-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/100462b81d20/mmr-25-06-12725-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/978b2d573aa5/mmr-25-06-12725-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/f6e88108b8ed/mmr-25-06-12725-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/ddb6419fefdd/mmr-25-06-12725-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/07c346712a50/mmr-25-06-12725-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/9c8f7c151d8e/mmr-25-06-12725-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/100462b81d20/mmr-25-06-12725-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/978b2d573aa5/mmr-25-06-12725-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/f6e88108b8ed/mmr-25-06-12725-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a517/9133959/ddb6419fefdd/mmr-25-06-12725-g05.jpg

相似文献

1
Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A.敲低 CDCA5 通过调控 PDS5A 抑制乳腺癌细胞的恶性进展。
Mol Med Rep. 2022 Jun;25(6). doi: 10.3892/mmr.2022.12725. Epub 2022 May 4.
2
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker.CDCA5 促进乳腺癌的进展,并可作为一种潜在的预后生物标志物。
Oncol Rep. 2022 Oct;48(4). doi: 10.3892/or.2022.8387. Epub 2022 Aug 25.
3
Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.细胞周期蛋白依赖性激酶1(CDK1)与细胞分裂周期相关蛋白5(CDCA5)共表达:它们在胃癌细胞系MGC-803中的作用
Med Sci Monit. 2020 Aug 6;26:e923664. doi: 10.12659/MSM.923664.
4
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.CDCA5 通过促进 E2F1 和 FOXM1 的结合加速乳腺癌的进展。
J Transl Med. 2024 Jul 8;22(1):639. doi: 10.1186/s12967-024-05443-w.
5
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.CDCA5 通过影响 ERK 信号通路促进前列腺癌的进展。
Oncol Rep. 2021 Mar;45(3):921-932. doi: 10.3892/or.2021.7920. Epub 2021 Jan 4.
6
Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.靶向细胞分裂周期相关蛋白5在口腔鳞状细胞癌中的治疗潜力
Oncotarget. 2016 Jan 19;7(3):2343-53. doi: 10.18632/oncotarget.6148.
7
Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.细胞分裂周期相关蛋白 5 的缺失通过激活 DNA 损伤反应促进透明细胞肾细胞癌中的细胞凋亡。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5377. Epub 2022 Jun 1.
8
Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.下调 CDCA5 可以抑制前列腺癌细胞的增殖、迁移和侵袭,并诱导其凋亡。
Crit Rev Eukaryot Gene Expr. 2021;31(1):29-40. doi: 10.1615/CritRevEukaryotGeneExpr.2020036803.
9
KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma.KLF5 介导的 CDCA5 表达促进上皮性卵巢癌的肿瘤发生和进展。
Exp Cell Res. 2023 Aug 1;429(1):113645. doi: 10.1016/j.yexcr.2023.113645. Epub 2023 May 27.
10
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.SPOP 通过 AKT 通路促进 CDCA5 的降解来调节前列腺癌的进展。
Neoplasia. 2021 Oct;23(10):1037-1047. doi: 10.1016/j.neo.2021.08.002. Epub 2021 Sep 10.

引用本文的文献

1
CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.CDCA5 通过促进 E2F1 和 FOXM1 的结合加速乳腺癌的进展。
J Transl Med. 2024 Jul 8;22(1):639. doi: 10.1186/s12967-024-05443-w.
2
Tubular Deletion Alleviates Acute Ischemic Kidney Injury and Facilitates Tissue Regeneration.管状缺失缓解急性缺血性肾损伤并促进组织再生。
Int J Mol Sci. 2022 Sep 5;23(17):10199. doi: 10.3390/ijms231710199.
3
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker.CDCA5 促进乳腺癌的进展,并可作为一种潜在的预后生物标志物。

本文引用的文献

1
PDS5A and PDS5B in Cohesin Function and Human Disease.黏连蛋白功能及人类疾病中的PDS5A和PDS5B
Int J Mol Sci. 2021 May 30;22(11):5868. doi: 10.3390/ijms22115868.
2
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer.三阴性乳腺癌新辅助治疗病理完全缓解的新型生物标志物及预测模型
J Cancer. 2021 Jan 1;12(3):936-945. doi: 10.7150/jca.52439. eCollection 2021.
3
Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria.
Oncol Rep. 2022 Oct;48(4). doi: 10.3892/or.2022.8387. Epub 2022 Aug 25.
基于阿尔及利亚肿瘤学家和乳腺科医生的诊断数据的女性乳腺癌流行病学。
Cancer Treat Res Commun. 2020;25:100220. doi: 10.1016/j.ctarc.2020.100220. Epub 2020 Oct 10.
4
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review.癌基因与抑癌基因在肿瘤发生中的作用:综述。
Anticancer Res. 2020 Nov;40(11):6009-6015. doi: 10.21873/anticanres.14622.
5
Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity.与乳腺癌、饮食和身体活动相关的调控性微小RNA的鉴定
Cancers (Basel). 2020 Sep 8;12(9):2555. doi: 10.3390/cancers12092555.
6
Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.三阴性乳腺癌的生物标志物:现状与未来展望。
Int J Mol Sci. 2020 Jun 27;21(13):4579. doi: 10.3390/ijms21134579.
7
Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference.早期乳腺癌证据审查会议执行摘要。
Obstet Gynecol. 2020 Jun;135(6):1457-1478. doi: 10.1097/AOG.0000000000003889.
8
CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.CDCA5通过失调线粒体介导的细胞凋亡、细胞周期调控以及PI3k/AKT/mTOR信号通路激活,在膀胱癌中发挥肿瘤促进因子的作用。
J Cancer. 2020 Feb 10;11(9):2408-2420. doi: 10.7150/jca.35372. eCollection 2020.
9
Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages.基于共表达网络分析鉴定乳腺癌的枢纽基因作为预测不同分期的工具。
Med Sci Monit. 2019 Nov 23;25:8873-8890. doi: 10.12659/MSM.919046.
10
PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection.PDS5 蛋白对于黏连蛋白的正常动态变化是必需的,并参与复制叉保护。
J Biol Chem. 2020 Jan 3;295(1):146-157. doi: 10.1074/jbc.RA119.011099. Epub 2019 Nov 22.